Navigation Links
Genencor Shows How Industrial Biotech Breakthroughs Contribute to the New Green Economy
Date:3/20/2009

the same time pushing boundaries to make better industries and more sustainable societies."

Genencor, a division of Danisco A/S, is a world leader in industrial biotechnology and a pioneer in enzyme innovation. Genencor improves process and product performance for a spectrum of industries, from biofuels and laundry detergents to animal nutrition and food. As part of a large global organization, Genencor has a manufacturing and distribution network that spans more than 40 countries. In collaboration with customers, technology leaders and other stakeholders, Genencor supplies competitive, biobased solutions. These innovations create value throughout the supply chain, from raw material to finished product.


'/>"/>
SOURCE Genencor
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Genencor Launches Accellerase(R) 1500, Next Step Toward Scale-Up of Cellulosic Ethanol
2. DuPont and Genencor Create World-Leading Cellulosic Ethanol Company
3. Genencor Launches First Ever Commercial Enzyme Product for Cellulosic Ethanol
4. Genencor Appoints New Executive Vice President - Technical Enzymes
5. DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)
6. Research Published in Nature Medicine Shows Disruption of Chemokine Interactions Inhibits Atherosclerosis in Mice
7. Study Shows Machine Perfusion Significantly Improves Transplant Results
8. Nature Medicine study shows Peregrines bavituximab can cure lethal virus infections
9. NPL research shows there could be no end in sight for Moore’s Law
10. Cryoablation of Early Invasive Ductal Breast Cancer With MRI Confirmation Shows Promising Clinical Benefits, According to Study Presented at RSNA
11. OGX-011 Shows Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... NATICK, Mass., Dec. 14 Boston Scientific Corporation ... of a public offering of $2 billion aggregate principal ... registration statement. The public offering consists of $850 ... million of 6.00 percent notes due January 2020 and ... Boston Scientific plans to use the net proceeds ...
(Date:12/14/2009)... has completed the delivery of Brookfield Engineering’s Powder Flow Tester ... enclosure with a smaller footprint and more compact design. ... ... 2009 -- ThermoFab, a US-based thermoforming company, has completed the ... move from sheet metal to a plastic enclosure with a ...
(Date:12/11/2009)... miRagen Therapeutics, Inc., a biopharmaceutical company focused ... therapeutics for cardiovascular and muscle disease, today announced ... plays a crucial role in the progression of ... and in neuromuscular synaptic regeneration in mice. ... of the journal Science , reveal miR-206 ...
(Date:12/11/2009)... Algeta ASA (OSE: ALGETA), the,cancer therapeutics company, ... the,US, the Tulane Cancer Center, New Orleans, ... clinical study of Alpharadin in men with,castration-resistant ... has metastasized to the skeleton. , ... SYMptomatic Prostate CAncer) study is a,double-blind, randomized, ...
Breaking Biology Technology:Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2miRagen announces discovery of key microRNA implicated in Lou Gehrig's disease 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 2Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 3Algeta Announces First US Patient Randomized in ALSYMPCA Phase III Study at Tulane Cancer Center, New Orleans 4
... DUBLIN, May 4 Circ Pharma Limited ("Circ ... they have entered into a,Development Agreement to develop ... moderate to moderately severe pain. , ... drug delivery,technology enabling once daily dosing. Circ,s technology ...
... May 4 Arno Therapeutics, Inc. (OTC Bulletin Board: ... today announced that it has voluntarily filed a Form ... order to deregister its common stock under the Securities ... effective immediately, Arno,s obligation to file periodic and other ...
... Medivation, Inc. (Nasdaq: MDVN ) ... with management to discuss first quarter 2009 financial results and ... at 4:30 p.m. Eastern Time. A press release for ... after markets close on May 11, 2009.Interested parties may call ...
Other Biology Technology:Circ Pharma Limited Enters Into Development Agreement for Chrono Tramadol With Elan Corporation Plc 2Arno Therapeutics to Deregister its Common Stock under the Exchange Act 2Arno Therapeutics to Deregister its Common Stock under the Exchange Act 3Medivation Announces First Quarter 2009 Financial Results Teleconference and Webcast on May 11, 2009 2
(Date:12/14/2009)... at Rice University and Baylor College of Medicine (BCM) ... in real time with MRI as it homes in ... and kills them with heat. The all-in-one particle is ... called "theranostics" that develops technologies physicians can use to ... The research is available online in the journal ...
(Date:12/14/2009)... clean-burning, renewable fuel that could help wean the nation ... ozone, compared with gasoline, especially in winter, according to ... Ozone production from both gasoline and E85, a blend ... is greater in warm sunny weather than during the ... and sunlight contribute to ozone formation. But E85 produces ...
(Date:12/14/2009)... Engineering Society (BMES) have founded a new journal ... CVET is a forum for research on ... The first issue of the new quarterly journal will ... publications at Springer, Annals of Biomedical Engineering ... Cardiovascular Engineering and Technology will present a wide ...
Breaking Biology News(10 mins):Tracking new cancer-killing particles with MRI 2Ethanol-powered vehicles generate more ozone than gas-powered ones 2Ethanol-powered vehicles generate more ozone than gas-powered ones 3Biomedical Engineering Society's new journal to be published by Springer 2Third National Annual Salary Survey for Medical Interpreters Underway 56903 1Third National Annual Salary Survey for Medical Interpreters Underway 56903 2RZN Nutraceuticals Receives United States Patent 26 Trademark Office Notice of Allowance for Proprietary HerbaZorb 28TM 29 Absorption and Delivery Sy 56901 1RZN Nutraceuticals Receives United States Patent 26 Trademark Office Notice of Allowance for Proprietary HerbaZorb 28TM 29 Absorption and Delivery Sy 56901 2Modelesque Abs Without the Crunches Are Now Possible With the High Definition Tummy Tuck 56900 1Modelesque Abs Without the Crunches Are Now Possible With the High Definition Tummy Tuck 56900 2
... Calif. Oct. 6, 2008 Complete Genomics Inc., ... formal launch as the world,s first provider of large-scale ... was established in March 2006, has been operating in ... For the past two and a half years, Complete ...
... before it has a chance to take root and ... discoveries in cancer prevention. Leading experts from around the ... this expanding and promising new field, with the hope ... , To help you take advantage of the meeting,s ...
... in a previously identified gene, a variation that likely ... lip. It is the first time a genetic variant ... both cleft lip and palate. , The study provides ... eventually help with diagnosis, prevention and treatment of cleft ...
Other Biology News:Complete Genomics launches, becomes world's first large-scale human genome sequencing company 2Complete Genomics launches, becomes world's first large-scale human genome sequencing company 3Complete Genomics launches, becomes world's first large-scale human genome sequencing company 4Study finds genetic variant plays role in cleft lip 2Study finds genetic variant plays role in cleft lip 3
Mixing speed from 750-3200RPM, small vortexing orbit of1.0mm...
This Universal 24" X 18" (61 X 45.7cm.) shaker platforms will accept any Thermo Forma shaker flask clip....
Spaced cover glasses to promote effective hybridization...
Antibodies were affinity purified using epitopes specific to RFC1 immobilized on solid support....
Biology Products: